Neuroendocrine and metabolic responses induced by Interleukin‐1
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
We have previously demonstrated that Interleukin‐1 (IL‐1), a cytokine mainly produced by activated monocytes, stimulates the pituitary–adrenal axis and affects glucose homeostasis. Comparative studies revealed that a β form of recombinant human IL‐1, similar to the mature peptide secreted naturally, is more powerful than other preparations of this monokine in stimulating adrenocorticotrophic hormone (ACTH) and corticosteone output. Another monokine, tumor necrosis factor (TNF), does not share with IL‐1 the capacity to induce such effects. In extending out studies to rats, we showed that increased ACTH and blood corticosterone levels are also induced by IL‐1 in this species. Another in vivo activity of IL‐1 relates to its capacity to induce a reduction in blood glucose levels. Our studies strongly suggest that, as opposed to other effects elicited by IL‐1, blockade of prostaglandin synthesis does not effect the capacity of IL‐1 to stimulate insulin output and produce hypoglycemia. Administration of IL‐1 to adrenalectomized mice, which are defective in counterregulatory mechanisms of glucose homeostasis, resulted in marked hypoglycemia. In contrast to the response observed in normal mice, in adrenalectomized animals this effect was paralleled by decreased blood insulin levels. IL‐1 was also injected into alloxan‐diabetic mice. A marked reduction in blood glucose levels occurred in these animals. This effect was already noticeable 1 hr after injection. After 2 hr and for at least another 6 hr, glucose levels of alloxan‐treated mice injected with IL‐1 remained within the normal range. A possible early increase in release of residual insulin in diabetic animals was ruled out. These data, together with previous studies, suggest that IL‐1‐induced hypoglycemia is not only mediated by its insulin secretagogue effect. The fact that IL‐1, a key mediator of immunological and inflammatory reponses, affects crucial mechanisms under control of the central nervous system suggests that it play a major role in neuroendocrine immunoregulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1
Berkenbosch, F., van Oers, J., del Rey, A., Tilders, F., & Besedovsky, H. (1987) · Science · doi:10.1126/science.2443979 · Cited by 1,151
Self-citation
Cited by
Immune-neuro-endocrine interactions: facts and hypotheses.
BESEDOVSKY, H. O., & REY, A. D. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-1-64 · Cited by 1,564
“The effect of several cytokines on the hypothalamus-pituitary axis in vivo is summarized in Table 5, which includes some specific details (282-336).”
BackgroundSelf-citationRegulation of the Hypothalamic-Pituitary-Adrenal Axis by Cytokines: Actions and Mechanisms of Action
TURNBULL, A. V., & RIVIER, C. L. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.1.1 · Cited by 1,297
Interleukin 1: the first interleukin
di Giovine, F. S., & Duff, G. W. (1990) · Immunology Today · doi:10.1016/0167-5699(90)90005-t · Cited by 338
Dunn, A. J. (1988) · Life Sciences · doi:10.1016/0024-3205(88)90522-x · Cited by 297
Treatment with an Interleukin 1 beta antibody improves glycemic control in diet-induced obesity
Osborn, O., Brownell, S. E., Sanchez-Alavez, M., Salomon, D., Gram, H., & Bartfai, T. (2008) · Cytokine · doi:10.1016/j.cyto.2008.07.004 · Cited by 160
“at 10- to 20-fold elevated levels over unstimulated levels, [58] and not in the 2- to 3-fold, chronically elevated range of IL-1b concentrations observed in obesity [59,60].”
Metadata
- Authors
- Besedovsky, H., & del Rey, A.
- Venue
- Journal of Neuroscience Research
- Publisher
- Wiley
- Published
- 1987-01
- Volume
- 18
- Issue
- 1
- Pages
- 172-178
- ISSN
- 0360-4012 (ISSN-L)
- 1097-4547
- OpenAlex
- W1995877824
- Cited by
- 81
- References
- 1
- FWCI
- 8.51
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.